Podcast: ISO 13485 Redo Takes Front Seat In Exclusive Interview With Ex-FDA International Quality Systems Expert Kim Trautman
This article was originally published in The Gray Sheet
Executive Summary
In her first interview since leaving the agency in January, FDA’s former international quality systems expert Kim Trautman – author of FDA’s Quality System Regulation and one of the chief architects of the global Medical Device Single Audit Program – talks to The Gray Sheet about what manufacturers should keep an eye on when it comes to quality systems standard ISO 13485, and also discusses her new role in the private sector.
You may also be interested in...
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.
Cidara Offloads Rezzayo, Will Focus On Universal Flu Preventative
Cidara conferred global rights to its novel antifungal to marketing partner, Mundipharma, while reacquiring a flu prophylaxis it licensed to J&J in 2021 and gaining $240m in new funding to back development.